US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lineage Cell Therapeutics Inc

1.67

-0.0300-1.76%

Post-market: 1.680.0100+0.60%19:32 EST

Volume:858.52K

Turnover:1.46M

Market Cap:384.65M

PE:-5.70

High:1.75

Open:1.71

Low:1.65

Close:1.70

52wk High:2.09

52wk Low:0.3651

Shares:230.33M

Float Shares:177.83M

Volume Ratio:0.62

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2930

EPS(LYR):-0.0930

ROE:-157.75%

ROA:-13.65%

PB:17.45

PE(LYR):-17.97

Loading ...

Overview Company News Filings

Lineage Cell Therapeutics Receives Gene-Edited iPSC Line From Factor Bioscience

Lineage Takes Delivery of Gene-Edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

THOMSON REUTERS

Lineage Cell Therapeutics Highlights 2025 Achievements and Outlines 2026 Priorities

BRIEF-Lineage Cell Therapeutics Inc - Withdrew CIRM Grant Application Filed In June 2025 - SEC Filing

Lineage Cell Therapeutics Inc - Withdrew Cirm Grant Application Filed in June 2025 - SEC Filing

THOMSON REUTERS

Lineage Cell Therapeutics Withdraws CIRM Grant Application and Plans Resubmission

Lineage Therap (LCTX) Gets a Buy from Craig-Hallum

Lineage Cell says first OpRegen development milestone under Roche pact achieved

Lineage Cell Therapeutics Achieves Milestone in Collaboration with Genentech and Roche

Lineage Cell Therapeutics Achieves $5 Million Milestone Payment Under Roche Agreement

Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million

Lineage Cell Therapeutics Inc: Sold 12 Mln Common Shares to Janus Henderson Investors at Purchase Price of $1.75 per Share

THOMSON REUTERS

Lineage Cell Therapeutics Sells 12 Million Shares to Janus Henderson for $21 Million

BRIEF-Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS

Lineage Cell Therapeutics Inc. to Report Third Quarter 2025 Results

Robert W. Baird Sticks to Its Buy Rating for Lineage Therap (LCTX)

Lineage Cell Therapeutics Expands into Type 1 Diabetes with New Islet Cell Transplant Program

Lineage Cell Therapeutics Initiates Cell Transplant Program in Type 1 Diabetes

THOMSON REUTERS

Lineage Cell Therapeutics Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LCTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LCTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LCTX\",,,,,undefined,":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":1.67,"timestamp":1770670800000,"preClose":1.7,"halted":0,"volume":858515,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.67,"latestTime":"19:32 EST","volume":2499,"amount":4220.9004642,"timestamp":1770683562021,"change":0.01,"changeRate":0.005988,"amplitude":0.017964},"delay":0,"changeRate":-0.01764705882352943,"floatShares":177829652,"shares":230327537,"eps":-0.29305,"marketStatus":"Post-Mkt","change":-0.03,"latestTime":"02-09 19:38:44 EST","open":1.71,"high":1.75,"low":1.65,"amount":1456444.94205,"amplitude":0.058824,"askPrice":1.7,"askSize":3,"bidPrice":1.65,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.29305,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"listingDate":699771600000,"exchange":"AMEX","adjPreClose":1.7,"preHourTrading":{"tag":"盘前","latestPrice":1.709,"preClose":1.7,"latestTime":"09:16 EST","volume":149,"amount":254.91000459999998,"timestamp":1770646572247,"change":0.009,"changeRate":0.005294,"amplitude":0.058824},"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.67,"latestTime":"19:32 EST","volume":2499,"amount":4220.9004642,"timestamp":1770683562021,"change":0.01,"changeRate":0.005988,"amplitude":0.017964},"volumeRatio":0.615417,"impliedVol":1.1968,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LCTX\",,,,,undefined,":{"symbol":"LCTX","floatShares":177829652,"roa":"-13.65%","roe":"-157.75%","lyrEps":-0.092955,"volumeRatio":0.615417,"shares":230327537,"dividePrice":0,"high":1.75,"amplitude":0.058824,"preClose":1.7,"low":1.65,"week52Low":0.3651,"pbRate":"17.45","psRate":"35.56","week52High":2.09,"institutionHeld":0.5861,"latestPrice":1.67,"committee":0.538462,"eps":-0.29305,"divideRate":0,"volume":858515,"delay":0,"ttmEps":-0.29305,"open":1.71,"prevYearClose":1.67,"prevWeekClose":1.7,"prevMonthClose":1.48,"prevQuarterClose":1.67,"fiveDayClose":1.54,"twentyDayClose":1.71,"sixtyDayClose":1.82,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LCTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"LCTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-08-12","symbol":"LCTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-05-13","symbol":"LCTX","fiscalQuarterEnding":"2025/03","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2025-03-10","symbol":"LCTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2024-11-14","symbol":"LCTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LCTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LCTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.7143,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1732165200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LCTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LCTX","date":"2026-02-06","current":-5.698686,"percent":0.740949,"low":-39.156329,"twenty":-17.691008,"median":-8.284849,"eighty":-5.544471,"high":-3.417558,"avg":-11.890735,"sd":9.202376,"marketCap":407110262},"quantilePoints":[{"date":"2021-02-12","current":-16.565709,"twenty":-8.556305,"median":-4.254464,"eighty":-1.948653,"marketCap":449974362},{"date":"2021-02-19","current":-15.40611,"twenty":-8.596047,"median":-4.254464,"eighty":-1.948653,"marketCap":418476156},{"date":"2021-02-26","current":-12.700377,"twenty":-8.636754,"median":-4.254464,"eighty":-1.948653,"marketCap":344980344},{"date":"2021-03-05","current":-10.215521,"twenty":-8.680579,"median":-4.254464,"eighty":-1.948635,"marketCap":277484189},{"date":"2021-03-12","current":-19.413142,"twenty":-8.734866,"median":-4.254464,"eighty":-1.948635,"marketCap":400861967},{"date":"2021-03-19","current":-20.039372,"twenty":-8.838806,"median":-4.254464,"eighty":-1.948635,"marketCap":413792998},{"date":"2021-03-26","current":-18.552075,"twenty":-8.898791,"median":-4.254464,"eighty":-1.948653,"marketCap":383081799},{"date":"2021-04-01","current":-19.256584,"twenty":-8.97471,"median":-4.254464,"eighty":-1.948653,"marketCap":397629209},{"date":"2021-04-09","current":-20.19593,"twenty":-9.089098,"median":-4.254464,"eighty":-1.948635,"marketCap":417025756},{"date":"2021-04-16","current":-17.925845,"twenty":-9.171566,"median":-4.254464,"eighty":-1.948635,"marketCap":370150768},{"date":"2021-04-23","current":-19.334863,"twenty":-9.294286,"median":-4.254464,"eighty":-1.948635,"marketCap":399245588},{"date":"2021-04-30","current":-21.448391,"twenty":-9.359541,"median":-4.254464,"eighty":-1.948635,"marketCap":442887818},{"date":"2021-05-07","current":-21.448391,"twenty":-9.43926,"median":-4.254464,"eighty":-1.948635,"marketCap":442887818},{"date":"2021-05-14","current":-26.813925,"twenty":-9.561671,"median":-4.254464,"eighty":-1.948635,"marketCap":366439105},{"date":"2021-05-21","current":-29.186839,"twenty":-9.61875,"median":-4.254464,"eighty":-1.948635,"marketCap":398867344},{"date":"2021-05-28","current":-28.119028,"twenty":-9.718549,"median":-4.254464,"eighty":-1.948635,"marketCap":384274636},{"date":"2021-06-04","current":-33.932667,"twenty":-9.75279,"median":-4.254464,"eighty":-1.948635,"marketCap":463723823},{"date":"2021-06-11","current":-34.051312,"twenty":-9.822598,"median":-4.254464,"eighty":-1.948635,"marketCap":465345235},{"date":"2021-06-18","current":-32.034336,"twenty":-9.911694,"median":-4.254464,"eighty":-1.948635,"marketCap":437781231},{"date":"2021-06-25","current":-33.695375,"twenty":-10.040686,"median":-4.254464,"eighty":-1.948635,"marketCap":460480999},{"date":"2021-07-02","current":-32.627564,"twenty":-10.110261,"median":-4.254464,"eighty":-1.948635,"marketCap":445888291},{"date":"2021-07-09","current":-32.74621,"twenty":-10.193557,"median":-4.254464,"eighty":-1.948635,"marketCap":447509703},{"date":"2021-07-16","current":-31.559753,"twenty":-10.310347,"median":-4.254464,"eighty":-1.948635,"marketCap":431295584},{"date":"2021-07-23","current":-31.559753,"twenty":-10.465962,"median":-4.254464,"eighty":-1.948635,"marketCap":431295584},{"date":"2021-07-30","current":-31.203816,"twenty":-10.617596,"median":-4.254464,"eighty":-1.948635,"marketCap":426431348},{"date":"2021-08-06","current":-31.192562,"twenty":-10.975173,"median":-4.254464,"eighty":-1.948635,"marketCap":426277558},{"date":"2021-08-13","current":-36.770459,"twenty":-11.297813,"median":-4.254464,"eighty":-1.948635,"marketCap":438745121},{"date":"2021-08-20","current":-32.139066,"twenty":-12.115056,"median":-4.254464,"eighty":-1.948635,"marketCap":383483331},{"date":"2021-08-27","current":-35.367007,"twenty":-12.545764,"median":-4.254464,"eighty":-1.948635,"marketCap":421999124},{"date":"2021-09-03","current":-39.156329,"twenty":-13.020647,"median":-4.254464,"eighty":-1.948635,"marketCap":467213316},{"date":"2021-09-10","current":-32.700447,"twenty":-13.440312,"median":-4.254464,"eighty":-1.948635,"marketCap":390181730},{"date":"2021-09-17","current":-35.788042,"twenty":-13.703037,"median":-4.254464,"eighty":-1.948635,"marketCap":427022923},{"date":"2021-09-24","current":-36.068733,"twenty":-13.972374,"median":-4.254464,"eighty":-1.948635,"marketCap":430372122},{"date":"2021-10-01","current":-36.349424,"twenty":-14.122109,"median":-4.254464,"eighty":-1.948635,"marketCap":433721322},{"date":"2021-10-08","current":-33.682864,"twenty":-14.349923,"median":-4.254464,"eighty":-1.948635,"marketCap":401903928},{"date":"2021-10-15","current":-32.981137,"twenty":-14.541173,"median":-4.254464,"eighty":-1.948635,"marketCap":393530929},{"date":"2021-10-22","current":-32.981137,"twenty":-14.688178,"median":-4.254464,"eighty":-1.948635,"marketCap":393530929},{"date":"2021-10-29","current":-31.99872,"twenty":-14.934123,"median":-4.254464,"eighty":-1.948635,"marketCap":381808731},{"date":"2021-11-05","current":-35.647697,"twenty":-15.116566,"median":-4.254464,"eighty":-1.948635,"marketCap":425348323},{"date":"2021-11-12","current":-35.546532,"twenty":-15.362534,"median":-4.254464,"eighty":-1.948635,"marketCap":426451740},{"date":"2021-11-19","current":-32.174529,"twenty":-15.469558,"median":-4.254464,"eighty":-1.948635,"marketCap":385997820},{"date":"2021-11-26","current":-27.959525,"twenty":-15.623654,"median":-4.254464,"eighty":-1.948635,"marketCap":335430420},{"date":"2021-12-03","current":-28.662026,"twenty":-15.783481,"median":-4.254464,"eighty":-1.948635,"marketCap":343858320},{"date":"2021-12-10","current":-28.100025,"twenty":-15.915804,"median":-4.254464,"eighty":-1.948635,"marketCap":337116000},{"date":"2021-12-17","current":-29.786027,"twenty":-16.048436,"median":-4.254464,"eighty":-1.948635,"marketCap":357342960},{"date":"2021-12-23","current":-37.654034,"twenty":-16.121004,"median":-4.254464,"eighty":-1.948635,"marketCap":451735440},{"date":"2021-12-31","current":-34.422531,"twenty":-16.293033,"median":-4.254464,"eighty":-1.948653,"marketCap":412967100},{"date":"2022-01-07","current":-27.819025,"twenty":-16.410672,"median":-4.265959,"eighty":-1.948671,"marketCap":333744840},{"date":"2022-01-14","current":-26.554524,"twenty":-16.469491,"median":-4.265959,"eighty":-1.948671,"marketCap":318574620},{"date":"2022-01-21","current":-22.05852,"twenty":-16.535791,"median":-4.265959,"eighty":-1.948671,"marketCap":264636060},{"date":"2022-01-28","current":-21.215519,"twenty":-16.598895,"median":-4.265959,"eighty":-1.948671,"marketCap":254522580},{"date":"2022-02-04","current":-20.513018,"twenty":-16.70477,"median":-4.265959,"eighty":-1.948671,"marketCap":246094680},{"date":"2022-02-11","current":-21.075019,"twenty":-16.754048,"median":-4.265959,"eighty":-1.948671,"marketCap":252837000},{"date":"2022-02-18","current":-20.513018,"twenty":-16.840533,"median":-4.265959,"eighty":-1.948671,"marketCap":246094680},{"date":"2022-02-25","current":-20.232018,"twenty":-16.953531,"median":-4.265959,"eighty":-1.948671,"marketCap":242723520},{"date":"2022-03-04","current":-17.703016,"twenty":-17.091102,"median":-4.265959,"eighty":-1.948671,"marketCap":212383080},{"date":"2022-03-11","current":-5.286279,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":227410451},{"date":"2022-03-18","current":-5.562428,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":239290101},{"date":"2022-03-25","current":-5.838577,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":251169752},{"date":"2022-04-01","current":-6.272525,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":269837774},{"date":"2022-04-08","current":-5.404629,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":232501730},{"date":"2022-04-14","current":-4.970681,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":213833707},{"date":"2022-04-22","current":-4.655082,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":200256964},{"date":"2022-04-29","current":-4.813395,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":207067421},{"date":"2022-05-06","current":-4.537216,"twenty":-17.215968,"median":-4.265959,"eighty":-1.948671,"marketCap":195186504},{"date":"2022-05-13","current":-3.904183,"twenty":-17.215968,"median":-4.238226,"eighty":-1.948671,"marketCap":190094682},{"date":"2022-05-20","current":-4.357347,"twenty":-17.215968,"median":-4.219315,"eighty":-1.948671,"marketCap":212159243},{"date":"2022-05-27","current":-4.5665,"twenty":-17.215968,"median":-4.219315,"eighty":-1.948671,"marketCap":222342887},{"date":"2022-06-03","current":-4.880229,"twenty":-17.215968,"median":-4.219315,"eighty":-1.948671,"marketCap":237618353},{"date":"2022-06-10","current":-4.880229,"twenty":-17.215968,"median":-4.219315,"eighty":-1.948671,"marketCap":237618353},{"date":"2022-06-17","current":-4.740794,"twenty":-17.215968,"median":-4.219315,"eighty":-1.948671,"marketCap":230829257},{"date":"2022-06-24","current":-4.775653,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":232526531},{"date":"2022-07-01","current":-5.472828,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":266472010},{"date":"2022-07-08","current":-5.99571,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":291931119},{"date":"2022-07-15","current":-5.71684,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":278352927},{"date":"2022-07-22","current":-5.542546,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":269866558},{"date":"2022-07-29","current":-5.71684,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":278352927},{"date":"2022-08-05","current":-5.960851,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":290233845},{"date":"2022-08-12","current":-5.260359,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":266516114},{"date":"2022-08-19","current":-4.858294,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":246145456},{"date":"2022-08-26","current":-4.858294,"twenty":-17.220513,"median":-4.218591,"eighty":-1.948653,"marketCap":246145456},{"date":"2022-09-02","current":-4.657261,"twenty":-17.173317,"median":-4.218591,"eighty":-1.948653,"marketCap":235960126},{"date":"2022-09-09","current":-4.355712,"twenty":-17.173317,"median":-4.218591,"eighty":-1.948653,"marketCap":220682133},{"date":"2022-09-16","current":-4.322206,"twenty":-17.173317,"median":-4.218591,"eighty":-1.948653,"marketCap":218984578},{"date":"2022-09-23","current":-3.953646,"twenty":-17.173317,"median":-4.162624,"eighty":-1.948653,"marketCap":200311474},{"date":"2022-09-30","current":-3.786119,"twenty":-17.173317,"median":-4.093704,"eighty":-1.948653,"marketCap":191823700},{"date":"2022-10-07","current":-4.020657,"twenty":-17.173317,"median":-4.09208,"eighty":-1.948653,"marketCap":203706584},{"date":"2022-10-14","current":-3.585086,"twenty":-17.173317,"median":-4.087668,"eighty":-1.948653,"marketCap":181638371},{"date":"2022-10-21","current":-3.652097,"twenty":-17.173317,"median":-4.054162,"eighty":-1.948653,"marketCap":185033480},{"date":"2022-10-28","current":-4.22169,"twenty":-17.173317,"median":-4.027127,"eighty":-1.948653,"marketCap":213891913},{"date":"2022-11-04","current":-4.389217,"twenty":-17.173317,"median":-4.027127,"eighty":-1.948653,"marketCap":222379687},{"date":"2022-11-11","current":-5.004517,"twenty":-17.173317,"median":-4.043164,"eighty":-1.949367,"marketCap":244765922},{"date":"2022-11-18","current":-5.004517,"twenty":-17.173317,"median":-4.059603,"eighty":-1.967886,"marketCap":244765922},{"date":"2022-11-25","current":-4.93501,"twenty":-17.173317,"median":-4.09208,"eighty":-1.982416,"marketCap":241366395},{"date":"2022-12-02","current":-5.213039,"twenty":-17.173317,"median":-4.09208,"eighty":-1.991968,"marketCap":254964502},{"date":"2022-12-09","current":-4.239938,"twenty":-17.173317,"median":-4.157034,"eighty":-2.004047,"marketCap":207371128},{"date":"2022-12-16","current":-4.44846,"twenty":-17.173317,"median":-4.188184,"eighty":-2.018552,"marketCap":217569708},{"date":"2022-12-23","current":-3.788141,"twenty":-17.173317,"median":-4.189511,"eighty":-2.025203,"marketCap":185274205},{"date":"2022-12-30","current":-4.06617,"twenty":-17.173317,"median":-4.217912,"eighty":-2.037751,"marketCap":198872311},{"date":"2023-01-06","current":-4.587474,"twenty":-17.173317,"median":-4.22169,"eighty":-2.042247,"marketCap":224368762},{"date":"2023-01-13","current":-5.282546,"twenty":-17.173317,"median":-4.239938,"eighty":-2.061961,"marketCap":258364029},{"date":"2023-01-20","current":-5.178285,"twenty":-17.173317,"median":-4.274692,"eighty":-2.083107,"marketCap":253264739},{"date":"2023-01-27","current":-4.865503,"twenty":-17.173317,"median":-4.288701,"eighty":-2.09181,"marketCap":237966869},{"date":"2023-02-03","current":-4.93501,"twenty":-17.173317,"median":-4.322206,"eighty":-2.103595,"marketCap":241366395},{"date":"2023-02-10","current":-4.691735,"twenty":-17.173317,"median":-4.344199,"eighty":-2.11083,"marketCap":229468052},{"date":"2023-02-17","current":-4.795995,"twenty":-17.173317,"median":-4.355712,"eighty":-2.11845,"marketCap":234567342},{"date":"2023-02-24","current":-4.239938,"twenty":-17.173317,"median":-4.357347,"eighty":-2.128679,"marketCap":207371128},{"date":"2023-03-03","current":-4.865503,"twenty":-17.173317,"median":-4.363578,"eighty":-2.138885,"marketCap":237966869},{"date":"2023-03-10","current":-9.260776,"twenty":-17.173317,"median":-4.389217,"eighty":-2.141985,"marketCap":243308369},{"date":"2023-03-17","current":-9.131255,"twenty":-17.129905,"median":-4.413706,"eighty":-2.143257,"marketCap":239905455},{"date":"2023-03-24","current":-9.455058,"twenty":-17.072628,"median":-4.413706,"eighty":-2.143257,"marketCap":248412740},{"date":"2023-03-31","current":-9.714101,"twenty":-17.018925,"median":-4.415277,"eighty":-2.143257,"marketCap":255218569},{"date":"2023-04-06","current":-8.936973,"twenty":-17.018925,"median":-4.415277,"eighty":-2.143257,"marketCap":234801083},{"date":"2023-04-14","current":-9.260776,"twenty":-17.030388,"median":-4.413706,"eighty":-2.143257,"marketCap":243308369},{"date":"2023-04-21","current":-9.131255,"twenty":-17.030388,"median":-4.413706,"eighty":-2.143257,"marketCap":239905455},{"date":"2023-04-28","current":-8.936973,"twenty":-17.041852,"median":-4.413706,"eighty":-2.143257,"marketCap":234801083},{"date":"2023-05-05","current":-9.066494,"twenty":-17.064778,"median":-4.413706,"eighty":-2.143257,"marketCap":238203998},{"date":"2023-05-12","current":-10.183609,"twenty":-17.064778,"median":-4.415277,"eighty":-2.1437,"marketCap":239905455},{"date":"2023-05-19","current":-9.679649,"twenty":-17.064778,"median":-4.452344,"eighty":-2.153081,"marketCap":228033160},{"date":"2023-05-26","current":-9.24622,"twenty":-17.064778,"median":-4.531641,"eighty":-2.161128,"marketCap":217822449},{"date":"2023-06-02","current":-9.24622,"twenty":-17.064778,"median":-4.55272,"eighty":-2.16822,"marketCap":217822449},{"date":"2023-06-09","current":-9.318456,"twenty":-17.064778,"median":-4.576987,"eighty":-2.168472,"marketCap":219524187},{"date":"2023-06-16","current":-11.052122,"twenty":-17.064778,"median":-4.622228,"eighty":-2.175745,"marketCap":260365897},{"date":"2023-06-23","current":-10.690942,"twenty":-17.075402,"median":-4.655082,"eighty":-2.17429,"marketCap":251857207},{"date":"2023-06-30","current":-10.113053,"twenty":-17.086027,"median":-4.657261,"eighty":-2.185865,"marketCap":238243304},{"date":"2023-07-07","current":-9.824109,"twenty":-17.086027,"median":-4.693384,"eighty":-2.195677,"marketCap":231436353},{"date":"2023-07-14","current":-10.292504,"twenty":-17.086027,"median":-4.72538,"eighty":-2.202525,"marketCap":242470813},{"date":"2023-07-21","current":-10.958925,"twenty":-17.086027,"median":-4.741205,"eighty":-2.208963,"marketCap":258170362},{"date":"2023-07-28","current":-10.310963,"twenty":-17.086027,"median":-4.791283,"eighty":-2.208963,"marketCap":242905656},{"date":"2023-08-04","current":-10.459322,"twenty":-17.086027,"median":-4.795995,"eighty":-2.208963,"marketCap":246400702},{"date":"2023-08-11","current":-11.202834,"twenty":-17.086027,"median":-4.830749,"eighty":-2.208963,"marketCap":246731206},{"date":"2023-08-18","current":-10.964475,"twenty":-17.086027,"median":-4.855313,"eighty":-2.208963,"marketCap":241481605},{"date":"2023-08-25","current":-10.726117,"twenty":-17.086027,"median":-4.865503,"eighty":-2.208963,"marketCap":236232005},{"date":"2023-09-01","current":-10.487759,"twenty":-17.086027,"median":-4.872866,"eighty":-2.208963,"marketCap":230982405},{"date":"2023-09-08","current":-10.964475,"twenty":-17.086027,"median":-4.907672,"eighty":-2.208963,"marketCap":241481605},{"date":"2023-09-15","current":-10.408306,"twenty":-17.086027,"median":-4.931231,"eighty":-2.209429,"marketCap":229232539},{"date":"2023-09-22","current":-10.090495,"twenty":-17.086027,"median":-4.964287,"eighty":-2.209429,"marketCap":222233072},{"date":"2023-09-28","current":-9.454874,"twenty":-17.086027,"median":-4.970681,"eighty":-2.209429,"marketCap":208234138},{"date":"2023-10-06","current":-10.487759,"twenty":-17.096651,"median":-5.004517,"eighty":-2.209306,"marketCap":230982405},{"date":"2023-10-13","current":-10.090495,"twenty":-17.096651,"median":-5.01013,"eighty":-2.224742,"marketCap":222233072},{"date":"2023-10-20","current":-9.375421,"twenty":-17.096651,"median":-5.039271,"eighty":-2.240353,"marketCap":206484271},{"date":"2023-10-27","current":-9.137063,"twenty":-17.232522,"median":-5.062856,"eighty":-2.261871,"marketCap":201234671},{"date":"2023-11-03","current":-8.978157,"twenty":-17.232522,"median":-5.089573,"eighty":-2.287649,"marketCap":197734938},{"date":"2023-11-10","current":-8.117743,"twenty":-17.232522,"median":-5.108778,"eighty":-2.294042,"marketCap":187235737},{"date":"2023-11-17","current":-7.186858,"twenty":-17.232522,"median":-5.151315,"eighty":-2.294042,"marketCap":165764873},{"date":"2023-11-24","current":-7.456943,"twenty":-17.232522,"median":-5.178773,"eighty":-2.294042,"marketCap":171994398},{"date":"2023-12-01","current":-7.450115,"twenty":-17.232522,"median":-5.20738,"eighty":-2.294042,"marketCap":171836910},{"date":"2023-12-08","current":-8.117743,"twenty":-17.1179,"median":-5.221028,"eighty":-2.294546,"marketCap":187235737},{"date":"2023-12-15","current":-7.323418,"twenty":-17.1179,"median":-5.262797,"eighty":-2.29662,"marketCap":168914633},{"date":"2023-12-22","current":-8.19361,"twenty":-17.347143,"median":-5.317299,"eighty":-2.320063,"marketCap":188985604},{"date":"2023-12-29","current":-8.724677,"twenty":-17.461765,"median":-5.339863,"eighty":-2.330484,"marketCap":201234671},{"date":"2024-01-05","current":-9.255744,"twenty":-17.576386,"median":-5.404629,"eighty":-2.357936,"marketCap":213483738},{"date":"2024-01-12","current":-8.572943,"twenty":-17.576386,"median":-5.472828,"eighty":-2.414136,"marketCap":197734938},{"date":"2024-01-19","current":-8.19361,"twenty":-17.691008,"median":-5.490258,"eighty":-2.452216,"marketCap":188985604},{"date":"2024-01-26","current":-8.269476,"twenty":-17.576386,"median":-5.542546,"eighty":-2.470788,"marketCap":190735471},{"date":"2024-02-02","current":-6.545784,"twenty":-17.576386,"median":-5.618491,"eighty":-2.496526,"marketCap":150978499},{"date":"2024-02-09","current":-8.82534,"twenty":-17.576386,"median":-5.647122,"eighty":-2.521479,"marketCap":203556467},{"date":"2024-02-16","current":-9.233921,"twenty":-17.576386,"median":-5.681981,"eighty":-2.56877,"marketCap":212980378},{"date":"2024-02-23","current":-8.743624,"twenty":-17.576386,"median":-5.722247,"eighty":-2.600179,"marketCap":201671685},{"date":"2024-03-01","current":-8.498476,"twenty":-17.461765,"median":-5.847426,"eighty":-2.709455,"marketCap":196017339},{"date":"2024-03-08","current":-9.912519,"twenty":-17.461765,"median":-5.958889,"eighty":-2.899483,"marketCap":212980378},{"date":"2024-03-15","current":-10.17867,"twenty":-17.461765,"median":-6.181815,"eighty":-2.922449,"marketCap":218698901},{"date":"2024-03-22","current":-11.933613,"twenty":-17.461765,"median":-6.958725,"eighty":-2.922449,"marketCap":256405608},{"date":"2024-03-28","current":-12.284602,"twenty":-17.461765,"median":-7.150864,"eighty":-2.922449,"marketCap":263946950},{"date":"2024-04-05","current":-12.63559,"twenty":-17.576386,"median":-7.233693,"eighty":-2.910966,"marketCap":271488291},{"date":"2024-04-12","current":-12.372349,"twenty":-17.576386,"median":-7.321142,"eighty":-2.910966,"marketCap":265832285},{"date":"2024-04-19","current":-10.529659,"twenty":-17.576386,"median":-7.427355,"eighty":-2.910966,"marketCap":226240243},{"date":"2024-04-26","current":-9.739934,"twenty":-17.461765,"median":-7.454569,"eighty":-2.922449,"marketCap":209272224},{"date":"2024-05-03","current":-9.226382,"twenty":-17.461765,"median":-7.562019,"eighty":-2.922449,"marketCap":198238052},{"date":"2024-05-10","current":-9.41756,"twenty":-17.461765,"median":-7.670181,"eighty":-2.964277,"marketCap":222781811},{"date":"2024-05-17","current":-8.461,"twenty":-17.461765,"median":-7.80008,"eighty":-3.071729,"marketCap":200153413},{"date":"2024-05-24","current":-8.221538,"twenty":-17.461765,"median":-7.893232,"eighty":-3.255459,"marketCap":194488694},{"date":"2024-05-31","current":-7.982075,"twenty":-17.461765,"median":-7.92393,"eighty":-3.55158,"marketCap":188823975},{"date":"2024-06-07","current":-7.742613,"twenty":-17.461765,"median":-7.958774,"eighty":-3.602677,"marketCap":183159255},{"date":"2024-06-14","current":-7.33872,"twenty":-17.461765,"median":-7.958774,"eighty":-3.655318,"marketCap":173604762},{"date":"2024-06-21","current":-7.208612,"twenty":-17.576386,"median":-7.966009,"eighty":-3.701192,"marketCap":170526931},{"date":"2024-06-28","current":-7.960524,"twenty":-17.576386,"median":-7.966009,"eighty":-3.759455,"marketCap":188314150},{"date":"2024-07-05","current":-7.127993,"twenty":-17.576386,"median":-7.966009,"eighty":-3.786119,"marketCap":168619809},{"date":"2024-07-12","current":-8.061896,"twenty":-17.576386,"median":-7.982075,"eighty":-3.804,"marketCap":190712214},{"date":"2024-07-19","current":-7.982075,"twenty":-17.576386,"median":-8.061896,"eighty":-3.821793,"marketCap":188823975},{"date":"2024-07-26","current":-8.141717,"twenty":-17.576386,"median":-8.141717,"eighty":-3.842677,"marketCap":192600454},{"date":"2024-08-02","current":-7.343509,"twenty":-17.576386,"median":-8.141717,"eighty":-3.859142,"marketCap":173718057},{"date":"2024-08-09","current":-7.047732,"twenty":-17.576386,"median":-8.141717,"eighty":-3.894758,"marketCap":170463498},{"date":"2024-08-16","current":-6.71748,"twenty":-17.576386,"median":-8.141717,"eighty":-3.92169,"marketCap":162475677},{"date":"2024-08-23","current":-7.402188,"twenty":-17.576386,"median":-8.141717,"eighty":-3.95643,"marketCap":179036715},{"date":"2024-08-30","current":-6.900953,"twenty":-17.576386,"median":-8.141717,"eighty":-4.008958,"marketCap":166913355},{"date":"2024-09-06","current":-6.526979,"twenty":-17.576386,"median":-8.141717,"eighty":-4.045364,"marketCap":157868045},{"date":"2024-09-13","current":-7.096919,"twenty":-17.576386,"median":-8.141717,"eighty":-4.087668,"marketCap":171653173},{"date":"2024-09-20","current":-7.338948,"twenty":-17.576386,"median":-8.141717,"eighty":-4.156268,"marketCap":177507132},{"date":"2024-09-27","current":-7.1828,"twenty":-17.576386,"median":-8.141717,"eighty":-4.19413,"marketCap":173730385},{"date":"2024-10-04","current":-7.104726,"twenty":-17.576386,"median":-8.141717,"eighty":-4.239938,"marketCap":171842011},{"date":"2024-10-11","current":-6.678443,"twenty":-17.576386,"median":-8.141717,"eighty":-4.275245,"marketCap":161531490},{"date":"2024-10-18","current":-7.083646,"twenty":-17.576386,"median":-8.141717,"eighty":-4.306819,"marketCap":171332150},{"date":"2024-10-25","current":-6.566016,"twenty":-17.576386,"median":-8.141717,"eighty":-4.336675,"marketCap":158812232},{"date":"2024-11-01","current":-6.36927,"twenty":-17.576386,"median":-8.141717,"eighty":-4.355712,"marketCap":154053530},{"date":"2024-11-08","current":-7.212468,"twenty":-17.576386,"median":-8.141717,"eighty":-4.357347,"marketCap":174447967},{"date":"2024-11-15","current":-8.116505,"twenty":-17.576386,"median":-8.141717,"eighty":-4.380294,"marketCap":163231026},{"date":"2024-11-22","current":-5.522738,"twenty":-17.576386,"median":-8.141717,"eighty":-4.413706,"marketCap":111067786},{"date":"2024-11-29","current":-6.268017,"twenty":-17.576386,"median":-8.141717,"eighty":-4.423665,"marketCap":126056096},{"date":"2024-12-06","current":-6.420361,"twenty":-17.576386,"median":-8.141717,"eighty":-4.490164,"marketCap":129119883},{"date":"2024-12-13","current":-5.545754,"twenty":-17.576386,"median":-8.141717,"eighty":-4.540317,"marketCap":111530660},{"date":"2024-12-20","current":-6.115673,"twenty":-17.576386,"median":-8.141717,"eighty":-4.5665,"marketCap":122992309},{"date":"2024-12-27","current":-5.447114,"twenty":-17.576386,"median":-8.141717,"eighty":-4.591101,"marketCap":109546914},{"date":"2025-01-03","current":-6.467489,"twenty":-17.576386,"median":-8.141717,"eighty":-4.622533,"marketCap":130067673},{"date":"2025-01-10","current":-6.356793,"twenty":-17.691008,"median":-8.141717,"eighty":-4.656981,"marketCap":127841469},{"date":"2025-01-17","current":-6.437897,"twenty":-17.691008,"median":-8.141717,"eighty":-4.691735,"marketCap":129472549},{"date":"2025-01-24","current":-6.970553,"twenty":-17.691008,"median":-8.141717,"eighty":-4.705935,"marketCap":140184783},{"date":"2025-01-31","current":-6.819475,"twenty":-17.691008,"median":-8.141717,"eighty":-4.734486,"marketCap":137146455},{"date":"2025-02-07","current":-7.608477,"twenty":-17.691008,"median":-8.141717,"eighty":-4.791283,"marketCap":153014074},{"date":"2025-02-14","current":-7.888885,"twenty":-17.691008,"median":-8.141717,"eighty":-4.795995,"marketCap":158653357},{"date":"2025-02-21","current":-7.674321,"twenty":-17.691008,"median":-8.177478,"eighty":-4.813395,"marketCap":154338278},{"date":"2025-02-28","current":-6.374455,"twenty":-17.691008,"median":-8.177478,"eighty":-4.845114,"marketCap":128196661},{"date":"2025-03-07","current":-5.963493,"twenty":-17.691008,"median":-8.19361,"eighty":-4.864061,"marketCap":119931801},{"date":"2025-03-14","current":-6.381067,"twenty":-17.691008,"median":-8.141717,"eighty":-4.865503,"marketCap":118745270},{"date":"2025-03-21","current":-6.215404,"twenty":-17.691008,"median":-8.141717,"eighty":-4.865503,"marketCap":115662460},{"date":"2025-03-28","current":-6.036244,"twenty":-17.691008,"median":-8.117743,"eighty":-4.865503,"marketCap":112328459},{"date":"2025-04-04","current":-5.306102,"twenty":-17.691008,"median":-8.061896,"eighty":-4.865503,"marketCap":98741259},{"date":"2025-04-11","current":-5.765048,"twenty":-17.691008,"median":-7.982075,"eighty":-4.865503,"marketCap":107281785},{"date":"2025-04-17","current":-5.031226,"twenty":-17.691008,"median":-7.963266,"eighty":-4.865503,"marketCap":93626078},{"date":"2025-04-25","current":-6.012928,"twenty":-17.691008,"median":-7.890143,"eighty":-4.865503,"marketCap":111894582},{"date":"2025-05-02","current":-6.021518,"twenty":-17.691008,"median":-7.872991,"eighty":-4.865503,"marketCap":112054431},{"date":"2025-05-09","current":-5.399364,"twenty":-17.691008,"median":-7.822434,"eighty":-4.865503,"marketCap":100476767},{"date":"2025-05-16","current":-6.524063,"twenty":-17.691008,"median":-7.822434,"eighty":-4.898565,"marketCap":105728962},{"date":"2025-05-23","current":-8.517918,"twenty":-17.691008,"median":-7.827581,"eighty":-4.923262,"marketCap":138041377},{"date":"2025-05-30","current":-9.666322,"twenty":-17.691008,"median":-7.890143,"eighty":-4.934254,"marketCap":156652414},{"date":"2025-06-06","current":-9.257687,"twenty":-17.691008,"median":-7.896321,"eighty":-4.970288,"marketCap":150030082},{"date":"2025-06-13","current":-9.898821,"twenty":-17.691008,"median":-7.966009,"eighty":-4.98198,"marketCap":160420293},{"date":"2025-06-20","current":-12.894535,"twenty":-17.691008,"median":-8.061896,"eighty":-5.004517,"marketCap":208968840},{"date":"2025-06-27","current":-13.587805,"twenty":-17.691008,"median":-8.117743,"eighty":-5.016673,"marketCap":220203970},{"date":"2025-07-03","current":-14.231757,"twenty":-17.691008,"median":-8.141717,"eighty":-5.039271,"marketCap":230639852},{"date":"2025-07-11","current":-14.372665,"twenty":-17.691008,"median":-8.141717,"eighty":-5.059327,"marketCap":232923415},{"date":"2025-07-18","current":-13.94994,"twenty":-17.691008,"median":-8.221538,"eighty":-5.089356,"marketCap":226072727},{"date":"2025-07-25","current":-16.204476,"twenty":-17.691008,"median":-8.269476,"eighty":-5.108778,"marketCap":262609733},{"date":"2025-08-01","current":-14.372665,"twenty":-17.691008,"median":-8.305646,"eighty":-5.125739,"marketCap":232923415},{"date":"2025-08-08","current":-13.397579,"twenty":-17.691008,"median":-8.363261,"eighty":-5.17887,"marketCap":217121160},{"date":"2025-08-15","current":-5.693557,"twenty":-17.691008,"median":-8.405026,"eighty":-5.20738,"marketCap":232923415},{"date":"2025-08-22","current":-6.530845,"twenty":-17.691008,"median":-8.405026,"eighty":-5.225701,"marketCap":267176859},{"date":"2025-08-29","current":-6.754121,"twenty":-17.691008,"median":-8.405026,"eighty":-5.269779,"marketCap":276311110},{"date":"2025-09-05","current":-6.698302,"twenty":-17.691008,"median":-8.416759,"eighty":-5.321327,"marketCap":274027548},{"date":"2025-09-12","current":-7.200675,"twenty":-17.691008,"median":-8.405026,"eighty":-5.357536,"marketCap":294579614},{"date":"2025-09-19","current":-8.651974,"twenty":-17.691008,"median":-8.416759,"eighty":-5.419773,"marketCap":353952249},{"date":"2025-09-26","current":-8.651974,"twenty":-17.691008,"median":-8.470913,"eighty":-5.445242,"marketCap":353952249},{"date":"2025-10-03","current":-9.6009,"twenty":-17.691008,"median":-8.498476,"eighty":-5.472828,"marketCap":392772818},{"date":"2025-10-10","current":-9.768358,"twenty":-17.691008,"median":-8.540578,"eighty":-5.489858,"marketCap":399623507},{"date":"2025-10-17","current":-9.489262,"twenty":-17.691008,"median":-8.597532,"eighty":-5.50757,"marketCap":388205693},{"date":"2025-10-24","current":-9.098527,"twenty":-17.691008,"median":-8.669919,"eighty":-5.530068,"marketCap":372220752},{"date":"2025-10-31","current":-10.27073,"twenty":-17.691008,"median":-8.741245,"eighty":-5.544471,"marketCap":420175573},{"date":"2025-11-07","current":-9.656719,"twenty":-17.691008,"median":-8.82534,"eighty":-5.562428,"marketCap":395056381},{"date":"2025-11-14","current":-6.447072,"twenty":-17.691008,"median":-8.82534,"eighty":-5.562428,"marketCap":436189566},{"date":"2025-11-21","current":-5.98145,"twenty":-17.691008,"median":-8.82534,"eighty":-5.562428,"marketCap":404686986},{"date":"2025-11-28","current":-6.303804,"twenty":-17.691008,"median":-8.82534,"eighty":-5.562428,"marketCap":426496465},{"date":"2025-12-05","current":-6.23217,"twenty":-17.691008,"median":-8.822296,"eighty":-5.562428,"marketCap":421649914},{"date":"2025-12-12","current":-6.124719,"twenty":-17.691008,"median":-8.732238,"eighty":-5.562428,"marketCap":414380088},{"date":"2025-12-19","current":-6.267987,"twenty":-17.691008,"median":-8.656941,"eighty":-5.562428,"marketCap":424073189},{"date":"2025-12-26","current":-6.017267,"twenty":-17.691008,"median":-8.576919,"eighty":-5.562428,"marketCap":407110262},{"date":"2026-01-02","current":-5.98145,"twenty":-17.691008,"median":-8.540578,"eighty":-5.562428,"marketCap":404686986},{"date":"2026-01-09","current":-6.303804,"twenty":-17.691008,"median":-8.498476,"eighty":-5.562428,"marketCap":426496465},{"date":"2026-01-16","current":-5.909816,"twenty":-17.691008,"median":-8.461,"eighty":-5.562428,"marketCap":399840436},{"date":"2026-01-23","current":-5.909816,"twenty":-17.691008,"median":-8.416759,"eighty":-5.562428,"marketCap":399840436},{"date":"2026-01-30","current":-5.62328,"twenty":-17.691008,"median":-8.340193,"eighty":-5.562428,"marketCap":380454233},{"date":"2026-02-06","current":-6.017267,"twenty":-17.691008,"median":-8.284849,"eighty":-5.544471,"marketCap":407110262}],"updateTime":1770683924802},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LCTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601975088","title":"Lineage Cell Therapeutics Receives Gene-Edited iPSC Line From Factor Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2601975088","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601975088?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:01","pubTimestamp":1767704478,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. has announced a significant milestone in its strategic collaboration with Factor Bioscience Inc. Under the partnership, Factor delivered a novel, gene-edited induced pluripotent stem cell  line with hypoimmunity edits to Lineage. This proprietary cell line, developed by Factor, is designed to support “off-the-shelf” cell transplant products for non-immune privileged and non-HLA matched indications, and includes a unique disease-specific edit. The delivery of the iPSC line triggered a success payment from Lineage to Factor, with Factor remaining eligible for further payments pending Lineage’s decision to enter into an exclusive license. The collaboration aims to combine Lineage’s cell therapy manufacturing expertise with Factor’s advanced gene-editing technology to develop innovative cell therapies for a range of serious medical conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDLKK3pZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2601897582","title":"Lineage Takes Delivery of Gene-Edited Hypoimmune Cell Line Under Partnership With Factor Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2601897582","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601897582?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:00","pubTimestamp":1767704401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA61GF5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2601881839","title":"Lineage Cell Therapeutics Highlights 2025 Achievements and Outlines 2026 Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2601881839","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601881839?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:01","pubTimestamp":1767618106,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc., a clinical-stage biotechnology company focused on allogeneic cell therapies, has issued a letter to shareholders highlighting its achievements in 2025 and outlining its corporate outlook for 2026. The company reported progress in key areas including achieving clinical and financial milestones, expanding manufacturing capabilities, and maintaining organizational focus. Lineage stated its commitment to pipeline diversification and expansion through a balanced approach to capital raising, investing, and managing partnered versus internally owned assets. The company plans to continue focusing on the development and commercialization of cell therapy products, particularly for non-oncology indications such as neurology, ophthalmology, and metabolic diseases. No specific financial figures or clinical trial results were disclosed in the update.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT str","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL3vrXCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2587273774","title":"BRIEF-Lineage Cell Therapeutics Inc - Withdrew CIRM Grant Application Filed In June 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2587273774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587273774?lang=en_us&edition=fundamental","pubTime":"2025-11-29 05:22","pubTimestamp":1764364976,"startTime":"0","endTime":"0","summary":"BRIEF-Lineage Cell Therapeutics Inc - Withdrew CIRM Grant Application Filed In June 2025 - SEC FilingNov 28  - Lineage Cell Therapeutics Inc LCTX.A:LINEAGE CELL THERAPEUTICS INC - WITHDREW CIRM GRANT APPLICATION FILED IN JUNE 2025 - SEC FILINGLINEAGE CELL THERAPEUTICS INC - CO INTENDS TO RESPOND TO FEEDBACK FROM CIRM, TO RESUBMIT CIRM GRANT APPLICATION JAN 2026 - SEC FILINGLINEAGE CELL THERAPEUTICS INC - WITHDRAWAL DOES NOT IMPACT OPC1 DEVELOPMENT - SEC FILINGFurther company coverage: LCTX.A ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nFWN3X40P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2587373745","title":"Lineage Cell Therapeutics Inc - Withdrew Cirm Grant Application Filed in June 2025 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2587373745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587373745?lang=en_us&edition=fundamental","pubTime":"2025-11-29 05:08","pubTimestamp":1764364114,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nFWN3X40P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2587432737","title":"Lineage Cell Therapeutics Withdraws CIRM Grant Application and Plans Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2587432737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587432737?lang=en_us&edition=fundamental","pubTime":"2025-11-29 05:06","pubTimestamp":1764363967,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. has withdrawn its application for a Clinical Trial  award from the California Institute for Regenerative Medicine , which was intended to support the continued clinical development of OPC1 for spinal cord injuries. The withdrawal followed feedback from CIRM, though no specific deficiencies were identified in the application. The company plans to address the feedback and submit a revised application in the next CIRM grant cycle, scheduled for January 2026. The withdrawal and planned resubmission do not affect the ongoing or planned development of OPC1 or the DOSED clinical study. No other organizations were mentioned as recipients of this grant application.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDLb5GSMw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2586471310","title":"Lineage Therap (LCTX) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2586471310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586471310?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:25","pubTimestamp":1764080743,"startTime":"0","endTime":"0","summary":"In a report released today, Albert Lowe from Craig-Hallum reiterated a Buy rating on Lineage Therap, with a price target of $3.00. According to Tip...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lineage-therap-lctx-gets-a-buy-from-craig-hallum-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lineage-therap-lctx-gets-a-buy-from-craig-hallum-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2586491985","title":"Lineage Cell says first OpRegen development milestone under Roche pact achieved","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491985","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586491985?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:20","pubTimestamp":1764004820,"startTime":"0","endTime":"0","summary":"According to a regulatory filing, as previously reported, in December 2021, Lineage Cell Therapeutics (LCTX) entered into a collaboration and licen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-cell-says-first-opregen-development-milestone-under-roche-pact-achieved-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-cell-says-first-opregen-development-milestone-under-roche-pact-achieved-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4224","LINE","LCTX"],"gpt_icon":0},{"id":"2586496407","title":"Lineage Cell Therapeutics Achieves Milestone in Collaboration with Genentech and Roche","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496407","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496407?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:25","pubTimestamp":1764001508,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. has entered into a worldwide collaboration with Roche and Genentech, a member of the Roche Group, for the development of OpRegen , a suspension of human allogeneic retinal pigment epithelial  cells aimed at treating geographic atrophy  secondary to dry age-related macular degeneration . Lineage recently announced the achievement of the first milestone under this collaboration, which is tied to manufacturing and clinical advancements in the OpRegen cell therapy program. The partnership includes potential milestone payments totaling up to $620 million and involves an exclusive global development effort currently being evaluated in a Phase 2a clinical study.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDLbqqtYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2586496661","title":"Lineage Cell Therapeutics Achieves $5 Million Milestone Payment Under Roche Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496661","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496661?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:16","pubTimestamp":1764001008,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. announced the achievement of the first development milestone under its collaboration and license agreement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. related to the OpRegen cell therapy program. This milestone, based on manufacturing and clinical advancements, triggered a $5 million milestone payment to Lineage, expected to be received within 30 days. Approximately 24.1% of the payment will be allocated to the Israel Innovation Authority and 21.5% to Hadasit Medical Research and Development Ltd., in accordance with existing agreements and regulations. OpRegen is currently in a Phase 2a clinical trial for the treatment of geographic atrophy secondary to age-related macular degeneration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL69mb4L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2584929358","title":"Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929358","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929358?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:58","pubTimestamp":1763571484,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Lineage Cell Therapeutics Q3 operating expenses USD 7.467 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:01:46.927 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDc4PV9w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2582377937","title":"Lineage Cell Therapeutics Inc: Sold 12 Mln Common Shares to Janus Henderson Investors at Purchase Price of $1.75 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2582377937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582377937?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:27","pubTimestamp":1762957627,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO148:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2582936377","title":"Lineage Cell Therapeutics Sells 12 Million Shares to Janus Henderson for $21 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582936377","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582936377?lang=en_us&edition=fundamental","pubTime":"2025-11-12 22:26","pubTimestamp":1762957575,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. announced the sale of 12 million common shares to Janus Henderson Investors at a price of $1.75 per share in a block transaction conducted under its at-the-market offering program. The transaction generated $21 million in gross proceeds for the company before fees and expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL7mSHT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JHG","BK4135","LCTX","LU0054578231.USD"],"gpt_icon":0},{"id":"2581778012","title":"BRIEF-Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581778012","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581778012?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:01","pubTimestamp":1762462906,"startTime":"0","endTime":"0","summary":"BRIEF-Lineage Cell Therapeutics Q3 Net Income USD -29.752 Million\n\n\nNov 06 (Reuters) - Lineage Cell Therapeutics Q3 operating expenses USD 7.467 million.\n\nQ3 income from operations USD -3.786 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLXC4E6D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2581122380","title":"Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581122380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581122380?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:01","pubTimestamp":1762462861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA82LCZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2579450691","title":"Lineage Cell Therapeutics Inc. to Report Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579450691","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579450691?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:00","pubTimestamp":1761825651,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc. will announce its third quarter 2025 financial and operating results on November 6, 2025, after the close of U.S. financial markets. Results will be released in the Investors section of Lineage's website. A conference call and webcast will be held on November 6, 2025, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. A live webcast of the conference call will be available online in the Investors section of Lineage's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on October 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL9rKV1G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2569741180","title":"Robert W. Baird Sticks to Its Buy Rating for Lineage Therap (LCTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569741180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569741180?lang=en_us&edition=fundamental","pubTime":"2025-09-24 06:15","pubTimestamp":1758665725,"startTime":"0","endTime":"0","summary":"In a report released today, Jack Allen from Robert W. Baird reiterated a Buy rating on Lineage Therap, with a price target of $5.00. The company’s ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/robert-w-baird-sticks-to-its-buy-rating-for-lineage-therap-lctx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/robert-w-baird-sticks-to-its-buy-rating-for-lineage-therap-lctx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XELB","LCTX"],"gpt_icon":0},{"id":"2565867466","title":"Lineage Cell Therapeutics Expands into Type 1 Diabetes with New Islet Cell Transplant Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2565867466","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565867466?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:00","pubTimestamp":1757332838,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc., a clinical-stage biotechnology company, has announced the launch of a new islet cell transplant program targeting Type 1 Diabetes . The initiative aims to leverage the company's manufacturing capabilities to address the challenge of large-scale islet cell production, a significant hurdle in the commercialization of islet cell therapies. Lineage intends to establish a production process that supports the entire dynamic culturing system, potentially allowing for widespread therapeutic application. CEO Brian M. Culley highlighted the potential of islet cell transplants to provide a functional cure for some diabetes patients and expressed confidence in achieving feasibility with modest investment. Success in this endeavor could pave the way for licensing opportunities or direct entry into the diabetes market, enhancing the company's position in the field of cell therapy.Disclaimer: This news brief was created by Public Technologies  using generative artifici","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL8QKHCx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2565686162","title":"Lineage Cell Therapeutics Initiates Cell Transplant Program in Type 1 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2565686162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565686162?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:00","pubTimestamp":1757332800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA21JZ4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2564804223","title":"Lineage Cell Therapeutics Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2564804223","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564804223?lang=en_us&edition=fundamental","pubTime":"2025-09-02 20:01","pubTimestamp":1756814494,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel allogeneic cell therapies for neurological and ophthalmic conditions, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 11:30am ET. The presentation will be led by Brian M. Culley, the company's Chief Executive Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on September 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDLHPW4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}